Actionable news
All posts from Actionable news
Actionable news in SNSS: Sunesis Pharmaceuticals, Inc.,

Departure Of Directors Or Certain

On October7, 2015, Sunesis Pharmaceuticals, Inc. (the Company) entered into a separation and consulting agreement (the Letter Agreement) with Adam R. Craig, M.D., Ph.D, under which Dr.Craig will relinquish his role as Executive Vice President, Development and Chief Medical Officer of the Company, effective December31, 2015, and provide consulting services to the Company on the regulatory process with the European Medicines Agency (EMA) and other matters until June30, 2017 or earlier termination. As part of this transition, Dr.Craig will be working approximately three days per week and entitled to receive not less than 60% of his...